GlaxoSmithKline PLC GSK:NYSE (Depositary Receipt)

LastChange / % ChangeDividend YieldVolumeAvg Volume (10 day)
45.77 0.52   1.15%5.80%36,6467.0M
Market data is delayed by at least 20 minutes.
Summary chart showing the current equity's performance of over the past 1 days
  • Advanced Charts
  • Embed the above chart in your blog or website

    Customize, copy, and then paste the generated code into your website.

Previous close 10/8/2014

Latest News Headlines for GlaxoSmithKline PLC

Revised Guidance, Development Milestones, Appointment, Program Extension, and Event Schedules - Research Reports on Mylan, Tekmira, GSK, Cigna and WellPoint

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, October 8, 2014 /PRNewswire/ -- Today, Analysts Review released its research reports regarding Mylan, Inc. (NASDAQ: MYL), Tekmira Pharmaceuticals Corp. (NASDAQ: TKMR), GlaxoSmithKline plc (NYSE: GSK), Cigna Corp. (NYSE: CI) and WellPoint Inc. (NYSE: WLP). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7013-100free.

Critical Alerts For Discovery Communications, GlaxoSmithKline, Illumina, Teekay and Gulfport Energy Released By InvestorsObserver

CHICAGO, Oct. 1, 2014 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DISCA, GSK, ILMN, TK and GPOR. To see what our analysts have discovered about a particular stock, read the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. (Note: You may have to copy this link into your browser then press the [ENTER] key.)

View more recent headlines

Company Background

GlaxoSmithKline plc (GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. GSK's principal pharmaceutical products include medicines in therapeutic areas: respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, antibacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines and human immunodeficiency virus (HIV). The Company operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare. On January 30, 2013, GSK acquired additional 29.3% interest in GlaxoSmithKline Consumer Healthcare Ltd. In May 2013, GlaxoSmithKline PLC acquired Okairos AG. In December 2013, Suntory Beverage & Food Ltd fully acquired Lucozade Ribena Suntory Limited from GlaxoSmithKline plc.

http://www.gsk.com

Loading...

collapse, right-facing arrow indicating collapsed view of sectionOverview

A table providing an overview of the stock
Bid | Size-- | --
Ask | Size-- | --
Price Open45.08
Previous Close45.77
Day High--
Day Low--
52 Week High2/18/2014 | 56.73
52 Week Low10/8/2014 | 45.04
% Off 52 Week High-19.32%
% Off 52 Week Low1.62%
Beta (5 Yr)0.6
Volatility Avg10/8/2014 | 15.95
10-Day Avg. Volume6,990,340
Market data is delayed by at least 20 minutes.

collapse, right-facing arrow indicating collapsed view of sectionFundamentals

A table providing the fundamentals of the stock
EPS (TTM)6/30/2014 | 3.14
P/E Ratio6/30/2014 | 14.6
Market CapLarge Cap | 111.0B
Shares Outstanding2.42B
Float2.4B

collapse, right-facing arrow indicating collapsed view of sectionDividends

A table providing information about the dividends of the stock
Dividend Yield5.80%
Ex-Date8/6/2014
Dividend Announcement7/23/2014
Date of Record8/8/2014
Payable$0.6482 - QRTR
Payable Date10/2/2014

collapse, right-facing arrow indicating collapsed view of sectionShare Statistics

A table providing statistics about shares of the stock
Shares Short10.52M
Short Ratio2.8
Short % of Float0.43%
As of 9/15/2014

Peers Information HelpGSK GlaxoSmithKline PLC vs. Peers

Peers 
GSK
GlaxoSmithKline PLC
-14.27%
The Procter & Gamble Company
3.40%
Johnson & Johnson
14.54%
Pfizer Inc.
-4.08%
Merck & Co., Inc.
20.24%
GSK
GlaxoSmithKline PLC
5.80%
The Procter & Gamble Company
3.06%
Johnson & Johnson
2.67%
Pfizer Inc.
3.54%
Merck & Co., Inc.
2.92%
GSK
GlaxoSmithKline PLC
1.15%
The Procter & Gamble Company
1.23%
Johnson & Johnson
2.46%
Pfizer Inc.
2.05%
Merck & Co., Inc.
2.94%
Compare these stocks